Dublin, April 14, 2026 (GLOBE NEWSWIRE) -- The "Antimicrobial Resistance (AMR) and 'One Health': Current Challenges, Regulatory Frontiers and Future Solutions (June 10, 2026)" training has been added to ResearchAndMarkets.com's offering.
Antimicrobial resistance (AMR) has emerged as a daunting global challenge, threatening to undermine decades of medical advancements.
It occurs when microorganisms such as bacteria, viruses, fungi, and parasites no longer respond to antimicrobial drugs, rendering treatments ineffective. This phenomenon jeopardises our ability to treat infections, leading to longer illnesses, increased mortality, and soaring healthcare costs. AMR's impact extends beyond human health; it affects veterinary medicine, agriculture, and the environment, creating a complex, interconnected 'One Health' crisis.
This comprehensive course delves into the intricacies of antimicrobial resistance (AMR) through the lens of the 'One Health' framework. Participants will gain insight into the regulatory landscapes governing AMR, understand the multifaceted challenges posed by AMR across different sectors, and explore innovative solutions, including alternatives to antibiotics like microbiome-derived antimicrobials and policy approaches. The course is designed to foster a holistic understanding of how human, animal, and environmental health are interconnected in the fight against AMR.
Who Should Attend:
- Pharmaceutical, biopharma and biotech professionals working in drug development, especially in antibiotics and AMR-related products
- Professionals involved in creating or implementing health and safety regulations
- Those working in animal health and interested in the impact of AMR on veterinary medicine
- Individuals focused on the environmental aspects of AMR
- Those studying AMR, 'One Health', or related fields
- Doctors, nurses, pharmacists, and other medical staff interested in AMR management
Key Topics Covered:
- Introduction to AMR, 'One Health' and antibiotic resistance
- Current regulatory landscape of AMR
- Cross-sector challenges and strategic approaches
- Emerging alternatives to antibiotics, case studies and practical solutions
- Discussing case studies in communities that can be used to decrease AMR
- Creative solutions and approaches to tackling AMR
CPD Hours: 6
Speakers
Linda Oyama
Linda Oyama is a microbiologist and lecturer at the School of Biological Sciences and Institute for Global Food Security, Queen's University Belfast, with a first-class Microbiology degree and a PhD in Biological Sciences.
Linda's research interests centre on understanding antimicrobial resistance (AMR) in microbiomes from a 'One Health; perspective through surveillance and epidemiological studies using meta-omics approaches. She aims to tackle AMR through the discovery and development of novel treatment options for various clinical and veterinary multidrug resistant (MDR) infections.
Linda is a pioneer and executive group member of the UK Young Academy. She leads the AMR Hub at QUB and the Futures AMR Network (FAN), a UKRI funded 'Transdisciplinary Network to Tackle Antimicrobial Resistance' across human and livestock systems, whose vision is to harness young talent for innovation in tackling the AMR challenge with the support of world- leading AMR experts. She has an infectious, positive personality and a passion for the support and development of others, being always ready to help.
For more information about this training visit https://www.researchandmarkets.com/r/s0kra3
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
